首页 | 本学科首页   官方微博 | 高级检索  
     

动脉内重组组织型纤溶酶原激活物局部溶栓治疗超早期脑梗死
引用本文:张彬,许丹,段淏,王枫,孙晓江. 动脉内重组组织型纤溶酶原激活物局部溶栓治疗超早期脑梗死[J]. 中华脑血管病杂志(电子版), 2008, 2(5): 257-261
作者姓名:张彬  许丹  段淏  王枫  孙晓江
作者单位:上海交通大学附属第六人民医院神经内科
摘    要:目的:探讨动脉内重组组织型纤溶酶原激活物(rtPA)局部溶栓治疗超早期脑梗死的有效性和安全性。方法:收集有完整资料的动脉溶栓病例21例,用NIHSS评分评定溶栓的疗效,用改良Rankin量表评价溶栓治疗90d时的转归,并对溶栓治疗的再通率、有症状脑出血发生率和病死率进行分析。结果:动脉内局部溶栓转归良好的比例为42.9%,有症状脑出血发生率为9.5%,病死率为9.5%。57.1%的溶栓病例完全再通,38.1%的病例部分再通。溶栓后再通等级为Ⅲ级的患者预后良好的比例为58.3%,再通等级为Ⅱ级的患者预后良好的比例为25%。大脑前动脉和大脑中动脉闭塞患者的动脉溶栓后的转归良好,动脉溶栓可降低颈内动脉和基底动脉闭塞的病死率结论:动脉内rtPA局部应用溶栓治疗超早期急性脑梗死安全、有效,再通等级与闭塞部位和预后相关。

关 键 词:重组组织型纤溶酶原激活物  急性脑梗死  动脉溶栓

Intra-Arterial Local Thrombolysis for Hyperacute Cerebral Infarction with Recombinant Tissue Plasminogen Activator
Bin Zhang,Dan Xu,Hao Duan,Feng Wang,Xiao-Jiang Sun. Intra-Arterial Local Thrombolysis for Hyperacute Cerebral Infarction with Recombinant Tissue Plasminogen Activator[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Version), 2008, 2(5): 257-261
Authors:Bin Zhang  Dan Xu  Hao Duan  Feng Wang  Xiao-Jiang Sun
Affiliation:Bin Zhang,Dan Xu,Hao Duan,Feng Wang,Xiao-Jiang Sun Department of Neurology,Shanghai Sixth People's Hospital,Affiliated to Shanghai Jiao Tong University,Shanghai 200233,China
Abstract:Objective:To investigate the effectiveness and safety of intra-arterial local thrombolysis for hyperacute cerebral infarction with recombinant tissue plasminogen activator(rtPA).Methods:Twenty-one patients with complete data treated with intra-arterial thrombolysis were collected.National Institutes of Health Stroke Scale(NIHSS)score and the modified Rankin scale evaluated the thrombolytic efficacy and the outcome of thrombolytic therapy at day 90,respectively.The recanalization rate of thrombolytic therapy...
Keywords:recombinant tissue plasminogen activator  cerebral infarction  intra-arterial thrombolysis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号